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Apelin receptor homodimer-
oligomers revealed by single-
molecule imaging and novel G 
protein-dependent signaling
Xin Cai1,2, Bo Bai2, Rumin Zhang2, Chunmei Wang2 & Jing Chen2,3
The apelin receptor (APJ) belongs to family A of the G protein-coupled receptors (GPCRs) and is a 
potential pharmacotherapeutic target for heart failure, hypertension, and other cardiovascular 
diseases. There is evidence APJ heterodimerizes with other GPCRs; however, the existence of APJ 
homodimers and oligomers remains to be investigated. Here, we measured APJ monomer-homodimer-
oligomer interconversion by monitoring APJ dynamically on cells and compared their proportions, 
spatial arrangement, and mobility using total internal reflection fluorescence microscopy, resonance 
energy transfer, and proximity biotinylation. In cells with <0.3 receptor particles/μm2, approximately 
60% of APJ molecules were present as dimers or oligomers. APJ dimers were present on the cell surface 
in a dynamic equilibrium with constant formation and dissociation of receptor complexes. Furthermore, 
we applied interference peptides and MALDI-TOF mass spectrometry to confirm APJ homo-dimer and 
explore the dimer-interfaces. Peptides corresponding to transmembrane domain (TMD)1, 2, 3, and 4, 
but not TMD5, 6, and 7, disrupted APJ dimerization. APJ mutants in TMD1 and TMD2 also decreased 
bioluminescence resonance energy transfer of APJ dimer. APJ dimerization resulted in novel functional 
characteristics, such as a distinct G-protein binding profile and cell responses after agonist stimulation. 
Thus, dimerization may serve as a unique mechanism for fine-tuning APJ-mediated functions.
The apelin receptor (APJ) is a member of the family A of G-protein-coupled receptors (GPCRs) and is involved 
in range of physiological and pathological functions including fluid homeostasis, anxiety, and depression, as well 
as cardiovascular and metabolic disorders1–3. APJ was first identified as an orphan GPCR with closest identity to 
the angiotensin II (Ang II) receptor. In 1998, the peptide apelin was isolated from bovine stomach extracts as the 
endogenous ligand of APJ. Subsequently, it was found that apelin could be hydrolyzed by angiotensin-converting 
enzyme 2 (ACE2) with high catalytic efficiency. Furthermore, the apelin-APJ system plays important roles in car-
diovascular homeostasis4–6. Initially, APJ was classically described as a monomeric transmembrane receptor that 
forms a ternary complex together with its ligand and associated G proteins7. More recently, increasing evidence 
indicates that APJ may interact with other GPCRs to form heterodimers, which may selectively modulate distinct 
intracellular signal transduction pathways2,8,9. However, the existence and distribution of APJ homodimers and 
higher-order oligomers, and their interfaces and potential functions, remains controversial and has been exten-
sively debated.
Here, we explored the characteristics of human APJ using total internal reflection fluorescence microscopy 
(TIRFM), resonance energy transfer, mass spectrometry (MS), and proximity biotinylation. Our results suc-
cessfully demonstrated the formation of APJ homodimers and oligomers at the single-molecule level. In cells 
with < 0.3 receptor particles/μ m2, approximately 60% of APJ molecules existed as homodimers or oligomers. 
Bioluminescence resonance energy transfer (BRET) and bimolecular fluorescence complementation (BiFC) also 
confirmed the existence of APJ homodimers and oligomers. Furthermore, our results also demonstrated homod-
imer and oligomer formation was independent of agonist stimulation, but the density of APJ was more prom-
inent for oligomer. APJ homodimers were present on the cell surface in a dynamic equilibrium with constant 
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formation and dissociation of new receptor complexes. Notably, HIV TAT-fused transmembrane domain (TMD) 
interference peptides (TMD1, TMD2, TMD3, and TMD4) disrupted APJ homodimerization in vitro. Moreover, 
different quaternary structures of APJ demonstrated novel signaling and functional characteristics, as APJ dimers 
activated only Gα i3 and Gα q, while distinct cellular responses were observed after agonist stimulation by xCEL-
Ligence instruments. Thus, APJ dimers could be a promising target for the development of more selective drugs 
that have fewer side effects.
Results
Visualization and analysis of APJ receptors on the surface of living cells. Prior to exploring the 
characteristics of APJ, single GFP molecules were analyzed10,11. To obtain GFP, a pET-21a (+ )-GFP plasmid was 
constructed and transfected into BL21(DE3) cells. GFP was induced for 5 h by addition of IPTG when OD600 
reached 0.7. Then, GFP was extracted (Fig. S1) and scattered on a FluoroDish via a glutaraldehyde cross-linking 
method. Individual GFP proteins were detected and visualized by TIRFM (488 nm) (Fig. S1A). The distribution of 
the intensity of 321 particles was analyzed and fitted to a Gaussian function. The results indicated a predominant 
peak, and the average intensity was 308.08 ± 3.38 (mean ± SD) (Fig. S1B).
Next, we applied the methods described in the SI to visualize APJ-GFP (the C-terminus of APJ was labeled 
with green fluorescent protein (GFP)-tags with precise 1:1 APJ/GFP ratio)12. Chinese hamster ovary (CHO) cells 
were transfected with APJ-GFP and observed by TIRFM (488 nm) (Fig. 1). To avoid serial and stochastic fluoro-
phores in the sample and temporally separated molecules that would be spatially indistinguishable, APJ-GFP 
expression levels were controlled (measured 8 h after transfection to ensure low expression levels [less than one 
receptor particle/μ m2]) so that the protein particles were counted and distinguished properly.
The distribution of the intensity of 1087 APJ-GFP particles was analyzed and fitted to a Gaussian function 
(equation (2)). As shown in Fig. 1A, the signal intensities of the individual spots fitted to three Gaussian dis-
tributions (a largely predominant peak (green curve), a peak of approximately double intensity (red curve), 
and a smaller peak of approximately three-fold intensity (green dotted curve). The average intensities were 
311.7 ± 12.37, 610.48 ± 5.85, and 896.87 ± 21.86 (mean ± SD), respectively. Given the results from the analysis 
of a single GFP molecule (Fig. S1), this revealed a mixed distribution of APJ monomers, dimers, and oligomers 
(1 = monomer, 2 = dimer, 3 = oligomer) (Fig. 1A). With 1760 spots from 11 cells, 40% were identified as mono-
mers, while 36% were dimers, and 24% were oligomers (Four independent experiments were performed and data 
were listed as a mean). The proportion of monomers, dimers, and higher-order oligomers increased with parti-
cle density (< 0.13 receptor particles/μ m2) and reached an equal proportion with > 0.13 receptor particles/μ m2. 
Notably, monomers and homodimers were present even at very low receptor densities (0.04 receptor particles/μ m2), 
while higher-order oligomers were found only at particle densities higher than 0.09, indicating APJ oligomers 
were more prominent at higher densities (Fig. S2). APJ monomers, dimers, and oligomers were distinguished 
according to the smallest normalized intensity and using equation (1) (Fig. 1B).
Formation of APJ homodimers and oligomers is agonist independent. We further assessed APJ 
interactions by co-immunoprecipitation (Co-IP), BRET1, and Förster resonance energy transfer (FRET). Co-IP 
analysis of hemagglutinin (HA)-tagged APJ and Myc-APJ in co-transfected CHO cells revealed that immu-
noreactive bands against the anti-HA and anti-Myc antibodies were evident only when both receptors were 
co-expressed (Fig. 2A). BRET studies were performed to confirm APJ homodimerization. In BRET saturation 
assays, CHO cells co-transfected with APJ-Rluc and APJ-EGFP resulted in a saturation curve, indicating APJ 
self-interaction. By contrast, the negative controls, mOX2α R-Rluc and mOX2α R- EGFP13, induced BRET signals 
increased with increasing concentrations of mOX2α R-EGFP in a quasi-linear manner (Fig. 2B,C), indicating a 
Figure 1. Visualization and quantitative analysis of green fluorescent protein (GFP)-tagged apelin 
receptor (APJ) on the surface of living cells. (A) Distribution of the intensity of APJ-GFP particles (n = 1087). 
Three peaks were observed for APJ-GFP (green, red and dotted green curves) (1 = monomer, 2 = dimer, 
3 = oligomer). (B) Total internal reflection fluorescence microscopy (TIRFM) image of Chinese hamster ovary 
(CHO) cells expressing APJ-GFP scattered on a FluoroDish. Four independent experiments at least were 
performed and data were listed as a mean.
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non-specific interaction. Furthermore, when cells co-expressing APJ-Rluc and APJ-EGFP (1:1) were treated with 
an antagonist ([Ala13]apelin-13) or agonist (apelin-12, 13, 15, 17, 36), BRET signals were not significantly different 
to those of unstimulated cells (Fig. 2D), indicating that the formation of APJ homodimers is antagonist and ago-
nist independent.
FRET sensitized emission (SE) was also performed to provide further evidence for APJ homodimerization in 
living cells. Correction factors β and γ showed the highest crosstalk values, whereas α and δ were rather small; α 
indicated 18% crosstalk for the acceptor channel into the donor channel; β indicated 60% crosstalk for the donor 
channel into the FRET channel; γ indicated 52% crosstalk for the acceptor channel into the FRET channel; and δ 
indicated 35% crosstalk for the donor channel into the acceptor channel (Table S1). No FRET signals were detect-
able in cells transfected with APJ-CFP or APJ-Venus alone. However, a notable FRET signal was detected in CHO 
cells co-transfected with APJ-CFP and APJ-Venus (Fig. 3A) and FRET efficiency was 52% calculated by equation 
(3) (Fig. 3B), indicating that APJ exists as a homodimer. Notably, as a result of membrane fluidity, the FRET signal 
was variable, which was consistent with monomer-dimer-oligomer dynamics on cell membranes (Movie 1).
Additionally, BiFC-BRET assays were performed to detect APJ oligomerization in living cells. Two 
non-fluorescent fragments (pCE-BiFC-VN173 and pCE-BiFC-VC155) of Venus fluorescent protein were sepa-
rately fused to APJ (APJ-VN173 and APJ-VC155) (Fig. 4A). CHO cells were then co-transfected with APJ-Rluc, 
APJ-VN173, and APJ-VC155 and observed with TIRFM. Detectable Venus fluorescence indicated that BiFC 
occurred, thereby indicating an interaction between APJ proteins (Fig. 4B). Moreover, a high BRET ratio was 
detected, which demonstrated the existence of APJ oligomers (Fig. 4C). Furthermore, when cells co-expressing 
these receptors were treated with an antagonist ([Ala13]apelin-13) or an agonist (apelin-12, 13, 15, 17, 36), the 
BRET ratio was the same as that of unstimulated cells (Fig. 4D), indicating that antagonist and agonist treatment 
did not induce receptor oligomerization.
TMD1, 2, 3, and 4 provide APJ dimer interfaces. TMDs are important for the formation of 
head-to-head interfaces in class A GPCR dimers14–18. To identify dimerization interfaces in the seven TMDs of 
APJ, the effects of cell-penetrating interference peptides (containing the sequence of the hydrophobic transmem-
brane helices) on APJ homodimerization were examined by MS. The sequence and molecular weight of each 
TMD are shown in Table 1 and Fig. S3. As shown in Fig. 5A, TMD1, TMD1 dimers, APJ, [APJ+ TMD1], APJ 
dimers, and [APJ+ TMD1] dimers were detected, suggesting that TMD1 is involved in the APJ self-interaction. 
Similar results were observed with TMD2, 3, and 4 (Fig. 5B,C,D). By contrast, TMD5, 6, and 7 lacked the effect 
Figure 2. Assessment of apelin receptor (APJ) dimerization using co-immunoprecipitation (Co-IP) and 
bioluminescence resonance energy transfer (BRET) assays. (A) Assessment of APJ homodimerization 
with Co-IP. Chinese hamster ovary (CHO) cells were either not transfected (mock) or transfected with HA-
APJ, Myc-APJ, or both (co-transfection). HA-APJ and Myc-APJ were also mixed (mix). Immunoprecipitated 
samples were resolved by SDS-PAGE and immunoblotted with an anti-Myc antibody (upper panel). Cell lysates 
were examined by immunoblotting with either an anti-Myc or anti-HA antibody (lower panels). (B) Assessment 
of APJ homodimerization with BRET1. (C) BRET saturation curves. (D) Assessment of effects of agonist-
treatment on dimerization by BRET1. For BRET, four independent experiments were performed with triplicate 
samples and the results were expressed as the mean ± SEM of four experiments (*P < 0.01, **P < 0.05 versus 
control group; NS, not significant versus unstimulated cells).
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demonstrated by TMD1, 2, 3, and 4 (Fig. 5E,F,G). The results indicate that TMD1, 2, 3, and 4 provide the most 
notable APJ dimer interfaces, not TMD5, 6 and 7.
To confirm the MS results that revealed the importance of TMD1, 2, 3, and 4 in the formation of APJ dimer 
interfaces, point mutations were constructed to explore the residues mediating APJ interactions according to 
previous reports19,20. Briefly, we generated 13 mutant receptors including “outward-facing” residues APJM361.40A, 
APJL401.44A, APJV732.48A, APJV1484.44A, and APJI2907.34A, as well as hydrophobic residues such as APJF541.58A, 
APJV802.55A, APJP832.58A, APJT983.44A, APJG993.45A, APJL2185.55A, APJL3047.48A, and APJF3077.51A21. Plasmids 
encoding Rluc-tagged mutant APJ receptors and EGFP-tagged wild-type (wt) APJ were transfected into CHO 
cells, followed by BRET1 detection as described above (Fig. 6A). Since the correct membrane location is a pre-
requisite for BRET, to exclude the possibility of incorrect APJ localization leading to a decreased BRET ratio, all 
mutants were observed by TIRFM before BRET measurement (Fig. 6B). Only mutants with the correct mem-
brane localization were used for BRET measurements. Notably, the APJM361.40A, APJL401.44A, and APJF541.58A 
mutants in TMD1, and the APJV732.48A, APJV802.55A, APJP832.58A mutants in TMD2 exhibited significantly 
lower BRET signals than wt APJ, also highlighting the importance of TMD1 and 2 in the formation of the APJ 
dimer interface. Notably, the mutations in TMD3 and 4 had little effect on the BRET signals, indicating that 
these mutations may not induce significant conformational changes in TMD3 and 4, or that TMD3 and 4 may be 
less important for APJ homodimerization in vitro (Fig. 6A). Moreover, the distribution of the intensity of 1189 
APJL401.44A-GFP (TMD1) particles was analyzed and fitted to a Gaussian function. Only one peak was observed 
for APJL401.44A (TMD1) (Fig. 6C), also suggesting that the Leu401.44 (TMD1) mutation disrupted the formation 
of APJ homodimers. Furthermore, the effects of the TMDs on APJ dimers were explored with BRET1. CHO cells 
co-transfected with APJ-Rluc and APJ-EGFP (1:3) were incubated with TMD1, 2, 3, 4, 5, 6, or 7 peptides at 37 °C 
(4 μ M) and detected by BRET1. As shown in Fig. 7, TMD1, 2, 3, and 4 significantly reduced APJ dimer BRET 
signals (by 55–75%), while TMD5, 6, and 7 had no significant effect. Thus, peptides corresponding to TMD1, 2, 
3, and 4 can disrupt the formation of APJ homodimers, further suggesting the involvement of these TMDs in the 
APJ homodimer interface (Fig. 7).
Measurement of APJ receptor homodimer dynamics on cell membranes. Proximity biotinylation 
was also used to examine APJ homodimer dynamics. Since biotin and streptavidin form a tight interaction with 
a slow off-rate (of days), biotinylated APJ would remain biotinylated even if the dimers dissociated. Here, we 
detected biotinylation using immunofluorescence imaging and found that acceptor peptide (AP)-APJ can be 
biotinylated, indicating the formation of APJ dimers (Fig. S4). Subsequently, we observed that the biotinylation 
increased linearly within ~15 min and reached saturation after 15 minutes, which likely reflects the continuous 
association and dissociation of APJ in a monomer-dimer dynamic equilibrium (Fig. 8A).
Proteins, including APJ, present on the membrane of living cells are typically dynamic (Movie 2); therefore, 
APJ could interact by coincidence and be falsely identified as an interaction partner, which represents one of the 
pitfalls of single-molecule co-tracking. Thus, we detected single-molecule co-tracking of APJ dimers by TIRFM 
and the co-tracking method was restrained to particle densities of < 1 particle/μ m2. The images indicated APJ 
exists in a dimeric form with short dimer lifetimes (Fig. 8B).
Novel G protein exchange induced by APJ dimers. GPCR dimers can exhibit novel signaling, different 
from that of their monomers. To explore the novel signaling of APJ dimers, we examined the signaling of APJ 
dimers using BiFC-BRET. First, we detected concentration for 50% of maximal effect (EC50) with xCELLigence 
Figure 3. Assessment of apelin receptor (APJ) dimerization with Förster resonance energy transfer 
sensitized emission (FRET-SE). (A) FRET images. Donor group: APJ-CFP only; Acceptor group: APJ-
Venus only; FRET group: APJ-CFP and APJ-Venus. (B) APJ homodimer FRET efficiency. Four independent 
experiments were performed with duplicate samples and the results were expressed as the mean ± SEM of four 
experiments (*P < 0.01 versus control group).
www.nature.com/scientificreports/
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Real-Time Cell Analyzer (RTCA). The different concentrations of apelin-13 (0 uM, 0.01 uM, 0.05 uM, 0.1 uM, 
0.5 uM, 1 uM, 5 uM, 10 uM, 100 uM) were added (Fig. 9A). The results were analyzed by RTCA Software 2.0, 
showing EC50 of APJ was 2.25 × 10−8 M and concentration for maximal effect was 10−6 M (Fig. 9B). For G pro-
tein dependent signaling, Gα -Rluc8, APJ-VN173, and APJ-VC155 were transfected into CHO cells and BRET 
signals measured after treatment with 1 μ M apelin-13. Cells expressing Gα -Rluc8 and APJ-Venus served as a 
positive control, and two negative controls (Gα -Rluc8 and APJ-VN173, Gα -Rluc8 and APJ-VC155A) were 
also introduced. These tags have been characterized and do not significantly alter the function of the wild type 
APJ22 (Fig. S5). To express a similar level, the mount of plasmid in positive controls and negative controls were 
Figure 4. Assessment of apelin receptor (APJ) oligomerization with bioluminescence resonance energy 
transfer - bimolecular fluorescence complementation (BiFC-BRET). (A) Principle of BiFC-BRET. The 
assay examines the formation of functional Venus by the complementation of protein fragments fused to APJ. 
Association of APJ enables formation of a bimolecular fluorescent complex. If all three tagged APJ proteins 
interact, BRET can occur. (B) TIRFM detection of APJ dimers (yellow particles) after BiFC. (C) Assessment of 
APJ oligomerization with BiFC-BRET. (D) Assessment of agonist-induced oligomerization. Four independent 
experiments were performed with triplicate samples and the results were expressed as the mean ± SEM of four 
experiments (*P < 0.01 versus control group; NS, not significant versus unstimulated cells).
TMD 
peptides Sequence
Molecular weight 
(Da)
TMD1 PAIYMLVFLLGTTGNGLVLWTVFYGRKKRRQRRR 4067.95
TMD3 IFVNMYASVFCLTGLSFDRYLAIYGRKKRRQRRR 4186.01
TMD5 VSSTTVGFVVPFTIMLTCYFFIAYGRKKRRQRRR 4085.9
TMD7 LMNIFPYCTCISYVNSCLNPFLYYGRKKRRQRRR 4261.10
TMD2 YGRKKRRQRRRFIASLAVADLTFVVTLPLWATYT 4054.84
TMD4 YGRKKRRQRRRVSGAVATAVLWVLAALLAMPVMV 3824.75
TMD6 YGRKKRRQRRRRLLSIIVVLVVTFALCWMPYHLV 4228.27
Table 1. Amino acid sequences of synthetic peptides derived from the transmembrane domains of APJ.
www.nature.com/scientificreports/
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transfected, same as that in experiment group. In addition, we have measured the expression levels of donor23 and 
acceptor before experiment (Fig. 10). With the positive controls, the increase in BRET signal was rapid, reaching 
a maximum ~5 min after apelin-13 addition for Gα i1, Gα i2, Gα i3, Gα q, and Gα o, while with cells expressing APJ 
tagged with VN173 and VC155, an increase in BRET was observed only for Gα i3 and Gα q. No changes in BRET 
were observed with the negative controls (Fig. 11). The results indicate that APJ monomers activate Gα i1, Gα i2, 
Gα i3, Gα q, Gα 13, and Gα o, but not Gα s and Gα 12, while APJ dimers activate only Gα i3 and Gα q, but not Gα 
i1, Gα i2, Gα s, Gα 12, Gα 13, and Gα o.
Disruption of APJ dimerization results in distinct cell responses after apelin-13 stimulation. 
Our previous study demonstrated that APJ monomers and APJ-bradykinin 1 receptor (B1R) heterodimers 
show different effects on the regulation of eNOS phosphorylation in human umbilical vein endothelial cells 
(HUVECs)24 eNOS is involved in the regulation of endothelial cell proliferation and/or migration. Here, we also 
measured the effects of interference peptides on apelin-13-induced cellular responses in HUVECs, as measured 
with an xCELLigence Real-Time Cell Analyzer. As shown in Fig. 12, apelin-13 stimulation elicited a further 
increase in the HUVEC cell index (CI); however, co-stimulation with interference peptides corresponding to 
Figure 5. The effects of interference peptides on apelin receptor (APJ) homodimerization as measured 
by matrix assisted laser desorption tandem time-of-flight (MALDI-TOF) mass spectrometry. (A) 
transmembrane domain 1 (TMD1), TMD1 dimers, TMD1 tetramers, APJ, [APJ + TMD1], APJ dimers, and 
[APJ + TMD1] dimers were detected (TMD1 MW = 4067.95). (B) TMD2, TMD2 dimers, TMD2 tetramers, 
APJ, [APJ + TMD2], APJ dimers, and [APJ + TMD2] dimers were detected (TMD2 MW = 4054.84). (C) 
TMD3, TMD3 dimers, TMD3 tetramers, APJ, [APJ + TMD3], APJ dimers, and [APJ + TMD3] dimers were 
detected (TMD3 MW = 4186.01). (D) TMD4, TMD4 dimers, TMD4 tetramers, APJ, [APJ + TMD4], APJ 
dimers, and [APJ + TMD4] dimers were detected (TMD4 MW = 3824.75). (E) TMD5, APJ, and APJ dimers 
were detected (TMD5 MW = 4085.9). (F) TMD6, APJ, and APJ dimers were detected (TMD6 MW = 4228.27). 
(G) TMD7, APJ, and APJ dimers were detected (TMD7 MW = 4261.10).
www.nature.com/scientificreports/
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TMD1, which was demonstrated to disrupt APJ homodimers, led to a decreasing trend in the CI compared to 
that before treatment, suggesting disruption of APJ homodimers induced distinct cell responses after agonist 
stimulation.
Discussion
GPCR dimerization and oligomerization in vivo and in vitro has been demonstrated by a range of techniques 
including co-IP, resonance energy transfer, proximity ligation assays, and protein fragment complementation 
assays25,26. Here, we examined APJ homodimerization and oligomerization with BRET, FRET, MS, TIRFM, and 
traditional Co-IP. Although previous studies demonstrated the existence of APJ heterodimerization with other 
GPCRs in vitro, no study to date has revealed the characteristics of human APJ homodimers and oligomers. Here, 
analyses of BRET, BiFC, and traditional Co-IP data provide solid evidence for the formation of functional APJ 
homodimers and oligomers. Furthermore, using single-molecule fluorescence imaging methods (TIRFM), we 
revealed monomer-to-dimer interconversion of APJ molecules on the cell membrane. TIRFM provides advan-
tages for monitoring membrane receptors within a thin layer 100 nm from the coverslip and improves the detec-
tion of single fluorescent molecules on the membrane27–29. Therefore, our observations likely reflect the dynamics 
of APJ on the cell membrane.
Figure 6. Identification of key amino acids involved in forming apelin receptor (APJ) dimer interfaces 
by point mutation. (A) Detection of a series of APJ mutants by BRET1. Four independent experiments were 
performed with triplicate samples and the results were expressed as the mean ± SEM of four experiments 
(*P < 0.01, **P < 0.05, NS, not significant versus wt APJ). (B) Visualization of a series of APJ mutants by total 
internal reflection fluorescence microscopy (TIRFM) in living cells. (C) Distribution of the intensity of 1189 
individual APJ-GFP mutant particles. One peak (red curve) was observed.
www.nature.com/scientificreports/
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We also measured the dynamics of the quaternary organization of APJ by observing GFP-labeled APJ as 
individual, mobile, fluorescent spots that were evenly distributed on the cell surface. In cells with less than 0.3 
receptor particles/μ m2, the proportion of APJ monomers, dimers, and oligomers was ~40%, ~36%, and ~24%, 
respectively. Agonist stimulation further increased the density of APJ oligomer, which has also been reported by 
several other recent studies in which agonist stimulation promoted GPCR dimerization30. Notably, even in the 
absence of extracellular stimulation, many receptors form dimers, including epidermal growth factor receptor31 
and various GPCRs32–34. Moreover, our observations also indicate that APJ receptors on the cell surface are in 
a dynamic equilibrium with constant formation and dissociation of new receptor complexes, which was also 
demonstrated previously30,35. Recently, using single-particle tracking experiments in cells expressing GFP-tagged 
adenosine A1 and mCherry-tagged A2A receptors, a preponderance of cell surface 2:2 receptor heteromers 
(dimer of dimers) that coupled with two G proteins was identified, suggesting the quaternary structure of the 
GPCR may be involved in the molecular intricacies of GPCR function12.
Additionally, we examined the interacting interfaces of APJ dimers using interference peptides and MS. The 
results demonstrated that peptides encoding TMD1, TMD2, TMD3, and TMD4 can bind to APJ, suggesting these 
TMDs are involved in interface formation. To the best of our knowledge, this is the first time that MS and interfer-
ence peptides were utilized to demonstrate the GPCR dimer and examine dimer interfaces simultaneously. Given 
the high sensitivity and accuracy of the mass analyzer, this method could provide extremely useful information 
for understanding GPCR structure and conformation changes during the formation of dimers. Furthermore, 
point mutations in TMD1 and TMD2 also disrupted the APJ dimers, which is consistent with previous findings 
that TMD1 and TMD2 are important for GPCR dimerization36–38. It is most likely that two of these are the dimer 
and two drive the tetramer interaction, which needs further investigation. Notably, these finding also highlight 
the therapeutic potential of interference peptides, as they can disrupt dimerization and influence receptor func-
tion. Indeed, Bouvier et al. showed that a peptide derived from TMD6 of β 2AR could disrupt the dimer and 
decrease receptor function39. Moreover, BRET also revealed that peptides corresponding to TMD1, 2, 3, and 4 can 
effectively disrupt the formation of APJ homodimers, which highlights the potential of these peptide for targeting 
distinct dimer-specific physiological effects.
Recent studies demonstrate that GPCR dimerization is of physiological relevance. In general, receptor dimeri-
zation or oligomerization is important in many signaling pathways, often as the first step for inducing intracellular 
signals upon ligand binding40–42. For example, orexin receptor–corticotropin-releasing factor receptor heteromers 
in the ventral tegmental area serve as targets for cocaine and promote long-term disruption of orexin-A–CRF 
negative crosstalk37. Therefore, GPCR dimer-monomer interconversion may be important for precise control 
of signal transduction. Here, APJ dimers induced distinct signaling and functional characteristics from those of 
monomers; APJ dimers activated only Gα i3 and Gα q. These novel characteristics will help develop more selective 
drugs that have fewer side effects. Recent studies demonstrate that monovalent drugs specific for GPCR heterod-
imers43 and bivalent ligands44,45 are powerful tools for evaluating activation of signaling pathways and cellular 
responses elicited by GPCR dimerization and oligomerization. Further studies are needed to generate specific 
agonists for APJ dimers/oligomers to investigate the novel G-protein binding characteristic of APJ dimers.
Our results also revealed distinct cellular responses profiles in interference peptide-treated versus 
non-interference peptide-treated HUVECs after apelin-13 stimulation. Recent studies used the xCELLigence 
system to monitor activation of endogenous GPCRs. For example, administration of UK14,304 (0.15 to 333 nM) 
to CHO-K1 cells expressing human α -adrenergic 2 A receptors (Gα i coupled) induces a dose-dependent increase 
in CI. Stimulating serum-deprived CHO-K1 cells with calcitonin (5 pM to 5 μ M) also resulted in a transient 
agonist-induced increase in CI lasting up to a few hours. Here, we also observed a transient increase in HUVEC 
CI after apelin-13 stimulation for 2–3 h; this observation is consistent with previous findings. Furthermore, 
Figure 7. The effect of interference peptides on apelin receptor (APJ) dimers. Chinese hamster ovary 
(CHO) cells were co-transfected with APJ-Rluc and APJ-EGFP (1:3) and incubated with interference peptides 
corresponding to transmembrane domain 1 (TMD1), TMD2, TMD3, TMD4, TMD5, TMD6, or TMD7 at 37 °C 
(4 μ M). BRET1 was detected as described above. Four independent experiments were performed with triplicate 
samples and the results were expressed as the mean ± SEM of four experiments (*P < 0.01; NS, not significant 
versus untreated (with TMD peptides) cells).
www.nature.com/scientificreports/
9Scientific RepoRts | 7:40335 | DOI: 10.1038/srep40335
Figure 8. Measurement of apelin receptor (APJ) homodimer dynamics. (A) Detection of biotinylated 
APJ with streptavidin-phycoerythrin (SA-PE) and flow cytometry. Biotinylation increased linearly within 
~15 min and reached saturation after 15 minutes. The results were analyzed using FlowJo software. (B) Single-
molecule co-tracking of APJ dimers by total internal reflection fluorescence microscopy (TIRFM). APJ proteins 
were initially monomers, formed a dimer for ~900 ms, and then rapidly dissociated into monomers. Four 
independent experiments were performed and data were listed as a mean.
www.nature.com/scientificreports/
1 0Scientific RepoRts | 7:40335 | DOI: 10.1038/srep40335
interference peptides abolished these apelin-13-induced changes, suggesting dimerization may be involved in 
APJ-mediated morphological or signaling alterations in HUVECs.
Taken together, this study advances our knowledge of the structure and function of APJ; however, much needs 
to be learned about the neuroanatomy, pharmacology, and signaling of APJ oligomers both in vitro and in vivo 
before new therapeutic drugs that affect their function can be developed.
Methods
Materials. Chinese hamster ovary cells and human umbilical vein endothelial cells were obtained from 
American Type Culture Collection (ATCC). All restriction enzymes were from NewEngland BioLabs. [Ala13] 
apelin-13, apelin-12, 13, 15, 17, 36 were purchased from Phoenix Pharmaceuticals. Lipofectamine 2000, streptavi-
din-phycoerythrin (SA-PE) and Opti-MEM I were obtained from Invitrogen Life Technologies. Isopropyl-beta-
D-thiogalactopyranoside (IPTG) and Coelenterazine h were obtained from Promega. HEPES-buffered phenol 
red− free medium, Dulbecco’s modified eagle medium and Incomplete RPMI-1640 culture medium were pur-
chased from Gibco. Anti-HA-agarose was obtained from Pierce Chemical Co. Polyclonal horseradish peroxi-
dase-conjugated goat anti-rabbit immuno-globulins/HRP was obtained from Zhong Shan Gold Bridge Biology 
Corporation (China). Anti-Myc antibody and anti-HA antibody were purchased from Cell Signaling Technology
Plasmid construction. APJ-VN173 and APJ-VC155 were generated by fusing either the N-terminal frag-
ment of Venus (Venus N: amino acids 1–172) or the C-terminal fragment of Venus (Venus C: amino acids 156–
239) to the C-terminus of the wild-type (wt) full-length apelin receptor. Gα i1-Rluc8, Gα i2-Rluc8, Gα i3-Rluc8, 
Gα q-Rluc8, Gα oa-Rluc8, and Gα s-Rluc8, pET-21a(+ )-GFP, FLAG-BirA-APJ, and HA-AP-APJ were constructed 
as described previously9,46.
Cell culture and cDNA transfection. CHO cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS; Invitrogen, Life Technologies) at 37 °C/5% CO2. 
HUVECs were cultured in RPMI-1640 medium supplemented with 10% (v/v) FBS at 37 °C/5% CO2. Transient 
transfections were performed with Lipofectamine 2000 M (Invitrogen, Life Technologies) according to the manu-
facturer’s protocol. Additionally, to ensure low cell expression levels, cells were analyzed 8–12 h after transfection.
Co-immunoprecipitation. CHO cells were co-transfected with HA-APJ and Myc-APJ or the vector control. 
48 h later, cells were lysed. After centrifugation at 4 °C for 15 min at 16,000 g, whole cell lysates were incubated 
with an anti-HA antibody and Protein G-Sepharose beads for 4 h with gentle rotation at 4 °C. The beads were 
washed four times with cell lysis buffer and precipitates were eluted with 4 × SDS-PAGE sample buffer and ana-
lyzed by Western blotting for anti-Myc immunoreactivity. To monitor protein expression levels, cell lysates of 
each sample were used for Western blots.
Western blotting. Transfected cells were lysed in lysis buffer. Cell lysates was separated by 10% SDS-PAGE 
followed by transfer to PVDF membranes. Proteins of interest were probed with primary and secondary antibod-
ies as described above. Enhanced chemiluminescence (ECL) kits were used to visualize protein bands. Films were 
scanned and bands analyzed using a ChemiDoc MP Imaging System (Bio-Rad).
Total internal reflection fluorescence microscopy (TIRFM). A commercial TIRF system (Leica 
Microsystems) equipped with a 100 × 1.47 NA oil-immersion objective, electron multiplying charge-coupled 
device camera, and a heatable mounting frame (M-H) was used Illumination was restricted within a single focal 
plane, with relatively short exposure times (three frames per second), and only 8% laser power for imaging events 
at the cell surface, thereby avoiding photobleaching during image acquisition. The penetration depth of the eva-
nescent field was ~150 nm. Additionally, the following factors were taken into consideration:
Figure 9. Concentration for 50% of maximal effect (EC50) with xCELLigence Real-Time Cell Analyzer 
(RTCA). (A) The different concentrations of apelin-13 (0 uM, 0.01 uM, 0.05 uM, 0.1 uM, 0.5 uM, 1 uM, 5 uM, 
10 uM, 100 uM) were added. (B) The results were analyzed by RTCA Software 2.0. All curves were plotted as the 
average of quadruplicate treatments, with error bars shown as SEM.
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Gaussian fitting. In our experiments, only CHO cells with < 0.3 receptor particles/μ m2 were analyzed. The 
single-particle tracking algorithm used to identify and track individual APJ receptors has been described previ-
ously. APJ monomers, dimers, and oligomers were distinguished according to the smallest normalized intensity 
and using equation (1):
= −y (x xc)/w
where y is the normalized intensity, w and xc are the standard deviation and the mean, respectively. Receptor par-
ticle intensities were analyzed by Gaussian fitting (see equation (2)). Briefly, the Gaussian fitting was performed 
with Origin 8.0 software and the following equation (2):
pi
= +
−
−
y y A
w
e
/2
x x
w0
2
( )c
2
2
where y is the frequency of the particles and w and xc are the standard deviation and mean, respectively.
BRET measurement. To monitor constitutive APJ interactions, CHO cells were transfected with 
APJ-Rluc and APJ-EGFP plasmids at a ratio of 1:1, 1:2, 1:3, 1:4, 1:5, and 1:6 to express a constant amount of 
donor-labeled protein with increasing amounts of acceptor-labeled protein. At 24 h post-transfection, cells were 
Figure 10. Expression levels of donor and acceptor were measured before BiFC-BRET experiment. (A) 
Gα i3-Rluc8, APJ-VN173, and APJ-VC155; (B) Gα s-Rluc8, APJ-VN173, and APJ-VC155. The expression 
levels of donor measured with BRET and expression levels of acceptor were measured with western blot. 
Four independent experiments were performed and the results were expressed as the mean ± SEM of four 
experiments (NS, not significant versus control group).
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trypsinized and plated on a 96 well microplate for 24 h in HEPES-buffered phenol red-free medium (Invitrogen, 
Life Technologies). Coelenterazine h (5 μ M; Promega) was added for BRET measurements using a Tristar LB941 
plate reader (Berthold) with an Rluc filter (400–475 nm) and a EGFP filter (500–550 nm). To monitor the induced 
interactions of APJ, BRET signals were measured as described above, with slight modifications. Briefly, cells were 
transiently transfected with APJ-Rluc and/or APJ-EGFP and stimulated with an antagonist ([Ala13]apelin-13) 
or agonist (apelin-12, 13, 15, 17, 36). To measure the effects of interference peptides on APJ dimers, CHO cells 
were co-transfected with APJ-Rluc and APJ-EGFP (1:3) and incubated with interference peptides corresponding 
to TMD1, TMD2, TMD3, TMD4, TMD5, TMD6, and TMD7 at 37 °C (4 μ M), and BRET1 detected as described 
above.
FRET SE. The donor plasmid APJ-CFP and receptor plasmid APJ-Venus were co-transfected into CHO cells 
as the FRET channel. In addition, the donor and acceptor channel are used to eliminate crosstalk into the FRET 
channel. FRET sample preparations must therefore include references of the donor in the absence of the acceptor 
(donor only control) and acceptor in the absence of the donor (acceptor only control). APJ-CFP and APJ-Venus 
were transfected into CHO cells as donor and acceptor channels, respectively, to obtain calibration coefficients 
to correct for excitation and emission crosstalk. After 12–24 h, FRET signals were detected with a FRET Kit for a 
Leica AM TIRF MC system (Leica Microsystems).
Figure 11. Identification of novel G-protein coupling to apelin receptor (APJ) homodimers by BiFC-
BRET. Kinetics of ligand-induced BRET between Gα -Rluc8 (8 subtypes), APJ-VN173, and APJ-VC155. BRET 
was measured after addition of 1 μ M apelin-13 for 30 min. (A) Gα i1-Rluc8, APJ-VN173, and APJ-VC155; (B) 
Gα i2-Rluc8, APJ-VN173, and APJ-VC155; (C) Gα i3-Rluc8, APJ-VN173, and APJ-VC155; (D) Gα q-Rluc8, 
APJ-VN173, and APJ-VC155; (E) Gα s-Rluc8, APJ-VN173, and APJ-VC155; (F) Gα o-Rluc8, APJ-VN173, and 
APJ-VC155; (G) Gα 12-Rluc8, APJ-VN173, and APJ-VC155; H. Gα 13-Rluc8, APJ-VN173, and APJ-VC155. 
Four independent experiments at least were performed with triplicate samples and the results were expressed as 
the mean ± SEM (*P < 0.01 versus unstimulated cells).
www.nature.com/scientificreports/
13Scientific RepoRts | 7:40335 | DOI: 10.1038/srep40335
Calculation of FRET efficiency. EA is the apparent FRET efficiency. A, B, C correspond to the intensities 
of the three signals (donor, FRET, acceptor) and α , β , γ , and δ are the calibration factors generated by the acceptor 
only and donor only references (equation (3)):
β γ α β
β δ
=
− × − × − ×
× − ×
iEA( ) B A C ( )
C (1 )
Design and synthesis of TMD peptides. Peptides derived from human APJ TMDs were custom syn-
thesized, and their primary sequences are shown in Table 1. The identity of the TMD peptide sequences was 
analyzed with liquid chromatography (LC)-MS. HIV TAT (YGRKKRRQRRR) was fused to the N-terminus of 
even-numbered TMDs and to the C-terminus of odd-numbered TMDs to obtain the correct orientation for the 
inserted peptide, because HIV TAT binds to phosphatidylinositol-(4,5)-bisphosphate found on the inner surface 
of the membrane47.
After custom synthesis, the identity of the TMD peptide sequences was analyzed using a LC-MS system 
(Shimadzu2020 and Water1010). The molecular weight of TMD1, 2, 3, 4, 5, 6, and 7 was 4067.95, 4054.84, 
4186.01, 3824.75, 4085.9, 4228.27, and 4261.1 Da, respectively. As shown in Fig. S3, all TMDs were synthesized 
correctly.
Mass spectrometry. MS was performed to identity APJ dimer interfaces in samples treated with TMD pep-
tides. Cells were transfected with APJ and, 48 h later, treated with or without the indicated HIV TAT-TMD fused 
peptides (4 μ M) for 60 min at 37 °C. Extracted proteins were immunoprecipitated using an anti-APJ antibody. 
Protein A/G PLUS-agarose beads were incubated with proteins for 2 h and washed four times with lysis buffer. The 
APJ complex was eluted from beads as described previously48. Then, the endogenous APJ complex was analyzed 
with an AXIMA matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) system (Shimazdu) 
in linear positive mode. The mass range was 4–10 kDa and the matrix was Sinapic Acid (SA), 10 mg/ml 
(50% acetonitrile (ACN), 50% H2O, 0.1% Sodium trifluoroacetate (TFA)). The results were calibrated with a 
Shimadzu MALDI calibration kit (Laser BioLabs).
Proximity biotinylation. Escherichia coli biotin ligase (BirA) and an AP were fused to APJ. In the pres-
ence of biotin, BirA can site-specifically biotinylate AP. Cells transfected with FLAG-BirA-APJ and HA-AP-APJ 
were incubated for a designated time (5, 10, 15, and 30 min) with biotinylation media (DMEM, 100 mM bio-
tin, 5 mM MgCl2, and 1 mM ATP) at 37 °C. Cells were then rinsed with PBS, detached with pancreatin, pel-
leted, and resuspended in 1% bovine serum albumin (BSA)/PBS for 15 min. Next, cells were labeled with 
streptavidin-phycoerythrin (SA-PE) in 1% BSA/PBS. Flow cytometry was performed with a BD FACSCalibur 
flow cytometer (BD Biosciences). PE was excited by 488 nm laser and emission examined using a 575/24 filter.
Real-time cell analyzer. An xCELLigence Real-Time Cell Analyzer (RTCA) DP system (ACEA 
Biosciences) was used to measure the effects of interference peptides on the apelin-13-induced cellular responses 
as reported via a cell index. A background step (step 1) was performed before other experimental steps. The 
background step was performed with each well of the E-Plate 16 containing only culture media (100 μ l/well) 
for 30 min at 37 °C, prior to the addition of 10000 HUVECs per well (100 μ l/well). Different concentrations of 
apelin-13 (1 nM, 0.1 μ M, and 10 μ M) with or without TMD1 (4 μ M) were then added during step 3. The schedule 
settings were as follows (RTCA Software 2.0):
Figure 12. Effect of interference peptides on apelin-13-induced cellular responses. Growth curves of human 
umbilical vein endothelial cells (HUVECs) treated with 10 μ M (A), 0.1 μ M (B), and 1 nM (C) apelin-13 (green 
line). Peptide-treated cells were treated with transmembrane domain 1 (TMD1) (4 μ M) and apelin-13 (red line). 
All curves were plotted as the average of quadruplicate treatments, with error bars shown as SEM.
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Step Sweep Status Sweeps Interval Unit Total Time
Step 1 2 2 1 minute 0:01:26
Step 2 145 241 10 minute 24:51:56
Step 3 181 181 1 minute 28:25:24
Statistical analysis. Results were analyzed using GraphPad Prism 5.0 and Origin 8.0 software, and are 
shown as the mean ± SEM. Student’s paired t-test was used to assess the statistical significance of differences. 
One-way ANOVA was adopted for multiple group comparisons. P < 0.05 was considered statistically significant.
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